Toyobo Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥40 | 0.0% |
| 2025 | ¥40 | 0.0% |
| 2024 | ¥40 | 0.0% |
| 2023 | ¥40 | 0.0% |
| 2022 | ¥40 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥375,720M | ¥399,921M | ¥414,265M | ¥422,032M |
| Gross Profit | ¥96,126M | ¥85,006M | ¥87,998M | ¥97,055M |
| Operating Income | ¥28,430M | ¥10,063M | ¥8,995M | ¥16,653M |
| Pretax Income | ¥16,007M | ¥1,940M | ¥6,942M | ¥9,350M |
| Net Income | ¥12,865M | -¥655M | ¥2,455M | ¥2,003M |
| EPS | ¥144.75 | -¥7.37 | ¥27.87 | ¥22.73 |
| Operating Margin | 7.57% | 2.52% | 2.17% | 3.95% |
| Balance Sheet | ||||
| Total Assets | ¥517,774M | ¥588,906M | ¥606,990M | ¥617,799M |
| Total Equity | ¥194,876M | ¥189,589M | ¥197,032M | ¥195,312M |
| Total Liabilities | ¥322,898M | ¥399,317M | ¥409,958M | ¥422,487M |
| Cash | ¥27,176M | ¥60,703M | ¥33,796M | ¥28,581M |
| Interest-bearing Debt | ¥187,691M | ¥225,166M | ¥242,091M | ¥261,070M |
| Equity Ratio | 37.64% | 32.19% | 32.46% | 31.61% |
| D/E Ratio | 0.96 | 1.19 | 1.23 | 1.34 |
| Cash Flow | ||||
| Operating CF | ¥17,097M | ¥7,798M | ¥21,595M | ¥30,118M |
| Investing CF | -¥24,608M | -¥36,011M | -¥58,784M | -¥46,386M |
| Financing CF | -¥1,729M | ¥61,295M | ¥8,260M | ¥10,490M |
| Free CF | -¥12,015M | -¥31,360M | -¥35,034M | -¥15,107M |
| Efficiency | ||||
| ROE | 6.60% | -0.35% | 1.25% | 1.03% |
| ROA | 2.48% | -0.11% | 0.40% | 0.32% |
Latest IR Information
-
Notice Regarding Full-Year Earnings Forecast and Dividend Forecast
Adjusted full-year consolidated earnings forecast for the fiscal year ending March 2027. Recalculated based on currently available information, factoring in the impact of the Middle East situation; strategy includes expanding sales and improving productivity to mitigate impact. Interim dividend is...
Read more -
FY2026 Q1 Financial Summary
Sales in Q1 grew by 13.4% year on year, with operating income up 29.0%. Segment-wise increases are observed in film, life science, environment, and functional materials, contributing to overall EBITDA growth. The outlook anticipates solid growth by segment.
Read more -
FY2027 Term Q1 Consolidated Financial Results for the Year Ending March 2027 (Japan GAAP) (Consolidated)
Consolidated net sales for the first quarter of the fiscal year ending March 2027 were 110,373 million yen (up 7.3% year over year), operating income was 7,132 million yen (up 28.1%), ordinary income was 6,626 million yen (up 55.3%), and...
Read more -
Completion of Share Buyback with Restricted Stock Compensation | July 2026
Toyobo has disposed of 40,690 shares of treasury stock held as restricted stock compensation, completing the payment. The disposal price was 1,710 yen per share, with a total of 69,579,900 yen. The recipients were 4 directors and 16 executive officers.
Read more -
Notice Regarding Share Buyback with Transfer Restrictions | July 2026
Toyobo plans to dispose of 40,690 shares of common stock at 1,710 yen per share on July 17, 2026, raising approximately 69,579,900 yen. The purpose of the scheme is to incentivize directors and officers and enhance corporate value.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,050
Rating Score: 1.67 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Toyobo Co., Ltd., together with its subsidiaries, manufactures, processes, and sells various films, life sciences, environmental and functional materials, and fibers and textiles products in Japan, China, Southeast Asia, and internationally. It operates through five segments: Film; Life Science; Environmental and Functional Materials; Functional Fibers and Trading; and Real Estate. The company offers industrial films for liquid crystal polarizers, displays, synthetic paper, labels, and ceramic capacitors; and packaging films for food packaging and other products. It also provides hollow fiber membranes for artificial kidneys and food, beverage, and industrial membranes; antithrombogenic polymers, nerve regeneration guidance conduits, and bone void fillers with collagen; contract manufacturing of injections, contract packaging, and contract testing; enzymes for diagnostic reagent, reagents for life science research, and IVD devices and reagents; and cosmetics ingredients. In addition, the company offers engineering plastics and elastomer; filter materials, equipment and device systems, and bag filters; reverse osmosis membrane modules; cushion materials for seatings, mattresses, and bedclothes; recycled polyester staple fibers and polyester spunbonds; polyethylene and PBO fibers; industrial adhesives and coatings, as well as water-wash letterpress plates; and fine chemicals and pharmaceutical intermediates. Further, it is involved in the provision of industrial fibers and civil materials, comfort evaluation technology, airbag fabrics, adhesives and coating materials, and clothing fiber functional materials; and rental and management of real estate properties. The company was founded in 1882 and is headquartered in Kita, Japan.